   |
Miguel Regueiro, Arthur Barrie III
he Guest Editors for this issue have assembled top experts to discuss only those
most challenging aspects of diagnosis and treatment of inflammatory bowel
disease. Emphasis is on comparing treatment paradigms, current and future
biologics agents, safety profile of therapeutics, and novel diagnostic and
prognostic tools for IBD. Articles are also devoted to pregnancy and IBD, IBD in
children, and post-operative management of IBD. |
